foxo4-dri longecity Targeted Apoptosis of Senescent Cells
Description
Tesamorelin Tesamorelin is the most rigorously studied GH-releasing peptide available, with FDA approval for a specific indication and a significant body of published clinical trial data
It does this by blocking the reuptake of dopamine, noradrenaline, and serotonin in the brain
Data on hyperbaric oxygen therapy (HBOT) for CRAO is scarce
While many sleep compounds target GABA receptors (promoting sedation), DSIP is studied for its potential to promote natural sleep architecturespecifically increasing slow-wave sleep without necessarily causing sedation
Beta-2 agonists
